Mustang Bio, INC Schedule 13G passive stakes

Intracoastal Capital LLC, along with Mitchell P. Kopin and Daniel B. Asher, reported a passive beneficial ownership of 4.99% in Mustang Bio, Inc.

Armistice Capital, LLC and Steven Boyd have filed an amended Schedule 13G, reporting a 4.99% beneficial ownership stake in Mustang Bio, Inc.'s common stock as of March 31, 2025.

Intracoastal Capital LLC, along with Mitchell P. Kopin and Daniel B. Asher, has disclosed a collective beneficial ownership of 8.8% in Mustang Bio, Inc., primarily through common stock and exercisable warrants.

Armistice Capital, LLC and Steven Boyd have disclosed a passive beneficial ownership of 5,106,287 shares, representing 9.99% of Mustang Bio, Inc.'s common stock as of December 31, 2024.

Intracoastal Capital LLC, along with Mitchell P. Kopin and Daniel B. Asher, has disclosed a 9.99% beneficial ownership stake in Mustang Bio, Inc. following a recent Securities Purchase Agreement.